Merck & Co's earnings and sales beat are significant indicators of the company's strong performance and operational efficiency. The substantial year-over-year growth in both earnings per share and sales revenue suggests that the company is on a solid growth trajectory. This outperformance is likely to instill investor confidence and could lead to a positive short-term impact on the stock price, as beats on both top and bottom lines are typically viewed favorably by the market.